Literature DB >> 20848162

The validity of the INR system for patients with liver disease.

Armando Tripodi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 20848162     DOI： 10.1007/s11239-010-0508-y

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  11 in total

1.  Comparative studies of rabbit and human recombinant tissue factor reagents.

Authors:  K W Denson; S V Reed; M E Haddon; B Woodhams; C Brucato; J Ruiz
Journal:  Thromb Res       Date:  1999-05-15       Impact factor: 3.944

2.  Reporting prothrombin time results as international normalized ratios for patients with chronic liver disease.

Authors:  A Tripodi; T Baglin; A Robert; S Kitchen; T Lisman; J F Trotter
Journal:  J Thromb Haemost       Date:  2010-03-30       Impact factor: 5.824

Review 3.  The International Normalized Ratio (INR) in the MELD score: problems and solutions.

Authors:  R J Porte; T Lisman; A Tripodi; S H Caldwell; J F Trotter
Journal:  Am J Transplant       Date:  2010-03-19       Impact factor: 8.086

4.  An International Sensitivity Index (ISI) derived from patients with abnormal liver function improves agreement between INRs determined with different reagents.

Authors:  Anne M Sermon; Julie M Smith; Rhona Maclean; Steve Kitchen
Journal:  Thromb Haemost       Date:  2010-02-19       Impact factor: 5.249

Review 5.  The international normalized ratio to prioritize patients for liver transplantation: problems and possible solutions.

Authors:  A Tripodi; V Chantarangkul; P M Mannucci
Journal:  J Thromb Haemost       Date:  2007-11-06       Impact factor: 5.824

6.  The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation.

Authors:  Armando Tripodi; Veena Chantarangkul; Massimo Primignani; Federica Fabris; Alessandra Dell'Era; Cinzia Sei; Pier Mannuccio Mannucci
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

7.  A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology.

Authors:  Laurent Bellest; Valérie Eschwège; Raoul Poupon; Olivier Chazouillères; Annie Robert
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

8.  Point-of-care coagulation monitors calibrated for the international normalized ratio for cirrhosis (INRliver) can help to implement the INRliver for the calculation of the MELD score.

Authors:  Armando Tripodi; Veena Chantarangkul; Massimo Primignani; Alessandra Dell'Era; Marigrazia Clerici; Francesca Iannuzzi; Alessio Aghemo; Massimo Cazzaniga; Francesco Salerno; Pier Mannuccio Mannucci
Journal:  J Hepatol       Date:  2009-05-20       Impact factor: 25.083

9.  Assessment of the validity of the INR system for patients with liver impairment.

Authors:  M J Kovacs; A Wong; K MacKinnon; K Weir; M Keeney; E Boyle; M Cruickshank
Journal:  Thromb Haemost       Date:  1994-06       Impact factor: 5.249

10.  Assessment of validity of INR system for patients with liver disease associated with viral hepatitis.

Authors:  YuXiang Wei; Jian Li; LiWen Zhang; DeHua Zheng; BingYi Shi; YuLong Cong
Journal:  J Thromb Thrombolysis       Date:  2010-07       Impact factor: 2.300
View more
  2 in total

Review 1.  Coagulopathy in liver disease: Lack of an assessment tool.

Authors:  Annabel Blasi
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

2.  Cholesterol esterification in plasma as a biomarker for liver function and prediction of mortality.

Authors:  Thorsten Kaiser; Benedict Kinny-Köster; Michael Bartels; Thomas Berg; Markus Scholz; Cornelius Engelmann; Daniel Seehofer; Susen Becker; Uta Ceglarek; Joachim Thiery
Journal:  BMC Gastroenterol       Date:  2017-04-20       Impact factor: 3.067
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.